• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Excitonic and vibrational coherence in artificial photosynthetic systems studied by negative-time ultrafast laser spectroscopy
  Dongjia Han,Bing Xue,Juan Du,Tomohiro Miyatake,Hitoshi Tamiaki,Xin Xing,Wei Yuan,Yanyan Li Phys. Chem. Chem. Phys., 2016,18, 24252-24260

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminotoluenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes Aminotoluenes

2-(4-Amino-3-methylphenyl)(ethyl)aminoethanol: A Comprehensive Overview

2-(4-Amino-3-methylphenyl)(ethyl)aminoethanol, with the CAS number 2359-51-5, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include an amino group, a methylphenyl moiety, and an ethylaminoethanol backbone. These structural elements contribute to its potential applications in various therapeutic areas, particularly in the development of novel drugs and therapeutic agents.

The chemical structure of 2-(4-Amino-3-methylphenyl)(ethyl)aminoethanol is defined by its molecular formula, C11H17NO2. The compound's structure allows it to interact with specific biological targets, making it a valuable candidate for drug discovery and development. Recent studies have highlighted its potential as a lead compound in the treatment of neurological disorders, cancer, and inflammatory conditions.

In the realm of medicinal chemistry, 2-(4-Amino-3-methylphenyl)(ethyl)aminoethanol has been explored for its ability to modulate various biological pathways. One of the key areas of interest is its interaction with neurotransmitter systems. Research has shown that this compound can influence the release and reuptake of neurotransmitters such as serotonin and dopamine, which are crucial for maintaining proper brain function. This property makes it a promising candidate for the development of drugs targeting mood disorders and neurodegenerative diseases.

Beyond its potential in neurological applications, 2-(4-Amino-3-methylphenyl)(ethyl)aminoethanol has also been investigated for its anti-inflammatory properties. Inflammation is a common underlying factor in many chronic diseases, including arthritis, cardiovascular diseases, and certain types of cancer. Studies have demonstrated that this compound can inhibit the production of pro-inflammatory cytokines and reduce oxidative stress, thereby mitigating the inflammatory response. These findings suggest that 2-(4-Amino-3-methylphenyl)(ethyl)aminoethanol could be developed into effective anti-inflammatory agents.

The pharmacological profile of 2-(4-Amino-3-methylphenyl)(ethyl)aminoethanol has been further enhanced by recent advancements in synthetic chemistry. Researchers have developed novel synthetic routes to produce this compound with high purity and yield. These methods not only improve the efficiency of large-scale production but also ensure that the final product meets stringent quality standards required for pharmaceutical applications.

In addition to its therapeutic potential, 2-(4-Amino-3-methylphenyl)(ethyl)aminoethanol has been studied for its safety and toxicity profiles. Preclinical studies have shown that this compound exhibits low toxicity at therapeutic doses, making it a suitable candidate for clinical trials. However, ongoing research is necessary to fully understand its long-term effects and potential side effects in human subjects.

The clinical development of 2-(4-Amino-3-methylphenyl)(ethyl)aminoethanol is an active area of research. Several Phase I and Phase II clinical trials are currently underway to evaluate its efficacy and safety in treating various conditions. Early results from these trials have been promising, with patients showing significant improvements in symptoms and quality of life. These findings underscore the potential of this compound to address unmet medical needs and improve patient outcomes.

Beyond its direct therapeutic applications, 2-(4-Amino-3-methylphenyl)(ethyl)aminoethanol has also found use as a building block in the synthesis of more complex molecules. Its versatile chemical structure allows it to be modified through various functional group manipulations, enabling the creation of a wide range of derivatives with tailored properties. This flexibility makes it an attractive starting material for researchers developing new drugs and materials.

In conclusion, 2-(4-Amino-3-methylphenyl)(ethyl)aminoethanol, with CAS number 2359-51-5, is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features and biological activities make it a valuable candidate for the development of novel therapeutic agents targeting neurological disorders, inflammation, and other chronic conditions. Ongoing research continues to uncover new applications and optimize its properties, paving the way for future breakthroughs in drug discovery and development.

• 91-99-6(N,N-Bis-(2-hydroxyethyl)-m-toluidine)
• 38264-80-1(1,4-Benzenediamine,N4-ethyl-N4-(2-methoxyethyl)-2-methyl-)
• 14876-25-6(2-[(4-amino-3-methyl-phenyl)-ethyl-amino]ethanol; nitric acid)
• 6629-52-3(Ethanol,2,2'-[(2,5-dimethylphenyl)imino]bis-)
• 28005-74-5(Ethanol,2,2'-[(2-methylphenyl)imino]bis-)
• 955368-98-6(2-4-(4-Amino-2-methylphenyl)-1-piperazinyl-1-ethanol)
• 1154310-29-8(2-[4-(4-Amino-3-methylphenyl)-1-piperazinyl]-1-ethanol)
• 51896-80-1(Ethanol,2,2'-[(methylphenyl)imino]bis-)
• 91-88-3(2-(N-Ethyl-m-toluidino)ethanol)
• 72225-29-7(Ethanol, 2-[(4-amino-2-methylphenyl)ethylamino]-)